Multiple System Atrophy Pipeline Therapeutics Assessment 2017 Multiple System Atrophy Pipeline Drugs and Therape | Página 2

2. The pipeline guide reviews pipeline therapeutics for Multiple System Atrophy (Central Nervous
System) by companies and universities/research institutes based on information derived from
company and industry-specific sources.
3. The pipeline guide covers pipeline products based on several stages of development ranging
from pre-registration till discovery and undisclosed stages.
4. The pipeline guide features descriptive drug profiles for the pipeline products which comprise,
product description, descriptive licensing and collaboration details, R&D brief, MoA & other
developmental activities.
5. The pipeline guide reviews key companies involved in Multiple System Atrophy (Central Nervous
System) therapeutics and enlists all their major and minor projects.
6. The pipeline guide evaluates Multiple System Atrophy (Central Nervous System) therapeutics
based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule
type.
7. The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
8. The pipeline guide reviews latest news related to pipeline therapeutics for Multiple System
Atrophy (Central Nervous System).
Buy Multiple System Atrophy - Pipeline Review H1 2017 Complete Report at
http://www.reportsnreports.com/purchase.aspx?name=1057929 .
List of Tables:
1. Number of Products under Development for Multiple System Atrophy (MSA or Shy-Drager
Syndrome or Multi-System Degeneration), H1 2017
2. Number of Products under Development by Companies, H1 2017
3. Products under Development by Companies, H1 2017
4. Number of Products by Stage and Target, H1 2017
5. Number of Products by Stage and Mechanism of Action, H1 2017
6. Number of Products by Stage and Route of Administration, H1 2017
7. Number of Products by Stage and Molecule Type, H1 2017
8. Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) -
Pipeline by AFFiRiS AG, H1 2017
9. Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) -
Pipeline by Corestem Inc, H1 2017
10. Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) -
Pipeline by Neuropore Therapies Inc, H1 2017
11. Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degenerat ion) -
Pipeline by Prana Biotechnology Ltd, H1 2017
12. Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) -
Discontinued Products, H1 2017.
List of Figures:
1. Number of Products under Development for Multiple System Atrophy (MSA or Shy-Drager
Syndrome or Multi-System Degeneration), H1 2017
2. Number of Products under Development by Companies, H1 2017
3. Number of Products by Stage and Targets, H1 2017